Trials / Unknown
UnknownNCT01630174
IMRT/Pemetrexed/Cisplatin in Esophageal Cancer
Phase I Study of Concurrent Selective Lymph Node Late Course Accelerated Hyper-fractionated Radiotherapy and Pemetrexed, Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Shandong Cancer Hospital and Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of concomitant late course accelerated hyperfractionation radiochemotherapy with pemetrexed and cisplatin in patients with esophagus cancer
Conditions
Timeline
- Start date
- 2009-10-01
- First posted
- 2012-06-28
- Last updated
- 2012-06-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01630174. Inclusion in this directory is not an endorsement.